Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
- PMID: 26378077
- PMCID: PMC4642440
- DOI: 10.4049/jimmunol.1500713
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Abstract
Alternative NF-κB signaling is crucial for B cell activation and Ig production, and it is mainly regulated by the inhibitor of κ B kinase (IKK) regulatory complex. Dysregulation of alternative NF-κB signaling in B cells could therefore lead to hyperactive B cells and Ig overproduction. In our previous, study we found that deleted in breast cancer 1 (DBC1) is a suppressor of the alternative NF-κB pathway to attenuate B cell activation. In this study, we report that loss of DBC1 results in spontaneous overproduction of Ig in mice after 10 mo of age. Using a double mutant genetic model, we confirm that DBC1 suppresses B cell activation through RelB inhibition. At the molecular level, we show that DBC1 interacts with alternative NF-κB members RelB and p52 through its leucine zipper domain. In addition, phosphorylation of DBC1 at its C terminus by IKKα facilitates its interaction with RelB and IKKα, indicating that DBC1-mediated suppression of alternative NF-κB is regulated by IKKα. Our results define the molecular mechanism of DBC1 inhibition of alternative NF-κB activation in suppressing B cell activation.
Copyright © 2015 by The American Association of Immunologists, Inc.
Conflict of interest statement
Disclosure of Conflicts of Interest. The authors declare no competing financial interests.
Figures







Similar articles
-
DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.J Immunol. 2014 Dec 1;193(11):5515-24. doi: 10.4049/jimmunol.1401798. Epub 2014 Oct 31. J Immunol. 2014. PMID: 25362179 Free PMC article.
-
Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.J Immunol. 2012 Dec 1;189(11):5185-93. doi: 10.4049/jimmunol.1102952. Epub 2012 Oct 19. J Immunol. 2012. PMID: 23087406 Free PMC article.
-
RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.Mol Cell Biol. 2005 Nov;25(22):10136-47. doi: 10.1128/MCB.25.22.10136-10147.2005. Mol Cell Biol. 2005. PMID: 16260626 Free PMC article.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.Oncogene. 1999 Nov 22;18(49):6867-74. doi: 10.1038/sj.onc.1203219. Oncogene. 1999. PMID: 10602462 Review.
Cited by
-
Multifaceted roles of CCAR family proteins in the DNA damage response and cancer.Exp Mol Med. 2024 Feb;56(1):59-65. doi: 10.1038/s12276-023-01139-1. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172598 Free PMC article. Review.
-
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.Exp Mol Med. 2023 Aug;55(8):1691-1701. doi: 10.1038/s12276-023-01058-1. Epub 2023 Aug 1. Exp Mol Med. 2023. PMID: 37524873 Free PMC article. Review.
-
USP22 controls iNKT immunity through MED1 suppression of histone H2A monoubiquitination.J Exp Med. 2020 May 4;217(5):e20182218. doi: 10.1084/jem.20182218. J Exp Med. 2020. PMID: 32069354 Free PMC article.
-
The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.Cell Rep. 2017 Jul 18;20(3):600-612. doi: 10.1016/j.celrep.2017.06.065. Cell Rep. 2017. PMID: 28723564 Free PMC article.
-
CCAR-1 works together with the U2AF large subunit UAF-1 to regulate alternative splicing.RNA Biol. 2024 Jan;21(1):1-11. doi: 10.1080/15476286.2023.2289707. Epub 2023 Dec 21. RNA Biol. 2024. PMID: 38126797 Free PMC article.
References
-
- Bonizzi G, Karin M. The two NF-[kappa]B activation pathways and their role in innate and adaptive immunity. Trends in Immunology. 2004;25:280–288. - PubMed
-
- Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U. Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture. The Journal of Experimental Medicine. 1998;187:147–159. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials